Feasibility of Allogeneic Stem Cell Transplantation in Xeroderma Pigmentosum Patients With Hematologic Malignancies, a Report From the SFGM ‐ TC (Société Francophone de Greffe de Moelle et de Thérapie Cellulaire)

This publication has 12 references indexed in Scilit:

• Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
  Leukemia, 2023
• Outcomes of TP53‐mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival
  American Journal of Hematology, 2022
• Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group
  American Journal of Hematology, 2020
• Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum
  Blood, 2019
• HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine
  Blood, 2015
• Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience
  Blood, 2013
• Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions
  British Journal of Dermatology, 2013
• Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair
  Journal of Medical Genetics, 2010
• A Prevalent Mutation with Founder Effect in Xeroderma Pigmentosum Group C from North Africa
  Journal of Investigative Dermatology, 2010
• Transcription-coupled DNA repair: two decades of progress and surprises
  Nature Reviews Molecular Cell Biology, 2008